Paul Mellon Urologic Cancer Institute
The Paul Mellon Urologic Cancer Institute was established in 2000 through to the generosity and vision of one man, Paul Mellon. Founded by a gracious bequest from his estate, the Paul Mellon Urologic Cancer Institute strives to investigate, to understand, to educate, to improve diagnosis, to develop treatment options, and to contribute significantly to research and discovery for the disease of prostate cancer.
Members of the Paul Mellon Urologic Cancer Institute comprise a select team of outstanding clinicians and scientists who conduct research in the area of prostate cancer, collaborate with University and external investigators on prostate cancer-related projects, and identify and promote progress in prostate cancer research and advances in treatment technique, equipment, and methodology.
The Paul Mellon Urologic Cancer Institute provides seed funds to University of Virginia investigators who presently work in prostate cancer research, who wish to redirect their research focus to prostate cancer, or who seek to broaden their current research by including prostate cancer study. Innovative clinical initiatives, such as the Robotic da Vinci Prostatectomy Program are also supported by the Mellon.